{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:29:30Z","timestamp":1785871770352,"version":"3.56.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T00:00:00Z","timestamp":1764460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2021\\u201301628"],"award-info":[{"award-number":["2021\\u201301628"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2024\\u201303166"],"award-info":[{"award-number":["2024\\u201303166"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016408","name":"G\u00f6ran Gustafssons Stiftelser","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","award":["23 2776 Pj"],"award-info":[{"award-number":["23 2776 Pj"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","award":["243519Pj01H"],"award-info":[{"award-number":["243519Pj01H"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118859","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T01:36:47Z","timestamp":1764812207000},"page":"118859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A comparative study of idarubicin and doxorubicin in a chemically-induced in vivo mouse model for hepatocellular carcinoma"],"prefix":"10.1016","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9039-8187","authenticated-orcid":false,"given":"Ada","family":"Lerma-Clavero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kopsida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Arendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Lennern\u00e4s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1406-9389","authenticated-orcid":false,"given":"Markus","family":"Sj\u00f6blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1987-7676","authenticated-orcid":false,"given":"Femke","family":"Heindryckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2025.118859_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.biopha.2025.118859_bib2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1535370219898141","article-title":"Mechanisms of liver fibrosis and its role in liver cancer","volume":"245","author":"Dhar","year":"2020","journal-title":"Exp. Biol. Med."},{"issue":"6","key":"10.1016\/j.biopha.2025.118859_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061663","article-title":"Molecular bases of drug resistance in hepatocellular carcinoma","volume":"12","author":"Marin","year":"2020","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.biopha.2025.118859_bib4","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/HEP.0000000000000237","article-title":"Mechanisms of drug resistance in HCC","volume":"79","author":"Ladd","year":"2024","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2025.118859_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"3","key":"10.1016\/j.biopha.2025.118859_bib6","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118859_bib7","doi-asserted-by":"crossref","first-page":"661","DOI":"10.21037\/hbsn-21-260","article-title":"Clinical practice of transarterial chemoembolization for hepatocellular carcinoma: consensus statement from an international expert panel of international society of multidisciplinary interventional oncology (ISMIO)","volume":"10","author":"Lu","year":"2021","journal-title":"Hepatobil. Surg. Nutr."},{"issue":"23","key":"10.1016\/j.biopha.2025.118859_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313051","article-title":"Limitations and possibilities of transarterial chemotherapeutic treatment of hepatocellular carcinoma","volume":"22","author":"Ebeling Barbier","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118859_bib9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1021\/acs.molpharmaceut.6b00886","article-title":"In vivo drug delivery performance of lipiodol-based emulsion or drug-eluting beads in patients with hepatocellular carcinoma","volume":"14","author":"Lilienberg","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2025.118859_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/17588359251316663","article-title":"Gastrointestinal side effects in hepatocellular carcinoma patients receiving transarterial chemoembolization: a meta-analysis of 81 studies and 9495 patients","volume":"17","author":"Arendt","year":"2025","journal-title":"Ther. Adv. Med Oncol."},{"key":"10.1016\/j.biopha.2025.118859_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116362","article-title":"Upcycling the anthracyclines: new mechanisms of action, toxicology, and pharmacology","volume":"459","author":"Bayles","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118859_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101205","article-title":"Doxorubicin and other anthracyclines in cancers: activity, chemoresistance and its overcoming","volume":"93","author":"Mattioli","year":"2023","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.biopha.2025.118859_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107431","article-title":"Recent developments of topoisomerase inhibitors: clinical trials, emerging indications, novel molecules and global sales","volume":"209","author":"Bondarev","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.biopha.2025.118859_bib14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3348\/kjr.2022.0395","article-title":"Complications related to transarterial treatment of hepatocellular carcinoma: a comprehensive review","volume":"24","author":"Lee","year":"2023","journal-title":"Korean J. Radiol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118859_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/hep.28453","article-title":"Lipiodol transarterial chemoembolization for hepatocellular carcinoma: a systematic review of efficacy and safety data","volume":"64","author":"Lencioni","year":"2016","journal-title":"Hepatology"},{"issue":"Pt A","key":"10.1016\/j.biopha.2025.118859_bib16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jcis.2020.07.092","article-title":"Interactions of anticancer drugs doxorubicin and idarubicin with lipid monolayers: new insight into the composition, structure and morphology","volume":"581","author":"Matyszewska","year":"2021","journal-title":"J. Colloid Interface Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118859_bib17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1365-2141.2002.03484.x","article-title":"In vitro evaluation of the efficacy of idarubicin in human tumour cells from patients with low-grade non-Hodgkin's lymphoma","volume":"117","author":"Aleskog","year":"2002","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118859_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ph14070639","article-title":"Anticancer drugs for intra-arterial treatment of colorectal cancer liver metastases: in-vitro screening after short exposure time","volume":"14","author":"Fohlen","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"12","key":"10.1016\/j.biopha.2025.118859_bib19","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.7150\/thno.55163","article-title":"Externally triggered smart drug delivery system encapsulating idarubicin shows superior kinetics and enhances tumoral drug uptake and response","volume":"11","author":"Lu","year":"2021","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.biopha.2025.118859_bib20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000474485","article-title":"Enhanced in vitro cytotoxicity of idarubicin compared to epirubicin and doxorubicin in rat prostate carcinoma cells","volume":"31","author":"Siegsmund","year":"1997","journal-title":"Eur. Urol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118859_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-065839","article-title":"Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival","volume":"12","author":"Nyman","year":"2022","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.biopha.2025.118859_bib22","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1148\/radiol.2019190789","article-title":"Is idarubicin the future of TACE?","volume":"291","author":"Padia","year":"2019","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.biopha.2025.118859_bib23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3748\/wjg.v26.i3.324","article-title":"Idarubicin vs doxorubicin in transarterial chemoembolization of intermediate stage hepatocellular carcinoma","volume":"26","author":"Roth","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2025.118859_bib24","article-title":"Idarubicin-loaded degradable hydrogel for TACE therapy enhances anti-tumor immunity in hepatocellular carcinoma","volume":"29","author":"Zhang","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biopha.2025.118859_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-0716-4542-0_2","article-title":"The tumor immune environment: advances in the cancer immunotherapy era","volume":"2926","author":"Ben-Baruch","year":"2025","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118859_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4254\/wjh.v7.i2.165","article-title":"P. Gerwins, Targeting the tumor stroma in hepatocellular carcinoma","volume":"7","author":"Heindryckx","year":"2015","journal-title":"World J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118859_bib27","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41598-023-27997-3","article-title":"Influence of extracellular matrix composition on tumour cell behaviour in a biomimetic in vitro model for hepatocellular carcinoma","volume":"13","author":"Calitz","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118859_bib28","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41598-024-84304-4","article-title":"Modelling hepatocellular carcinoma microenvironment phenotype to evaluate drug efficacy","volume":"15","author":"Cherradi","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2025.118859_bib29","article-title":"A patient-derived HCC spheroid system to model the tumor microenvironment and treatment response","volume":"7","author":"Crouchet","year":"2025","journal-title":"JHEP Rep."},{"issue":"24","key":"10.1016\/j.biopha.2025.118859_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413590","article-title":"Immune microenvironment and the effect of vascular endothelial growth factor inhibition in hepatocellular carcinoma","volume":"25","author":"Oura","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118859_bib31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/bcpt.13851","article-title":"Anakinra and dexamethasone treatment of idarubicin-induced mucositis and diarrhoea in rats","volume":"132","author":"Kullenberg","year":"2023","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118859_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0307414","article-title":"Melatonin mitigates chemotherapy-induced small intestinal atrophy in rats and reduces cytotoxicity in murine intestinal organoids","volume":"19","author":"Peters","year":"2024","journal-title":"PLOS One"},{"issue":"8","key":"10.1016\/j.biopha.2025.118859_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/apha.14188","article-title":"Endoplasmic reticulum stress in the pathogenesis of chemotherapy-induced mucositis: physiological mechanisms and therapeutic implications","volume":"240","author":"Heindryckx","year":"2024","journal-title":"Acta Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118859_bib34","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/bcpt.13790","article-title":"Evaluation and validation of chemotherapy-specific diarrhoea and histopathology in rats","volume":"131","author":"Dahlgren","year":"2022","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2025.118859_bib35","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbi.2024.05.039","article-title":"Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer","volume":"120","author":"Otto-Dobos","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"9","key":"10.1016\/j.biopha.2025.118859_bib36","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/MEG.0b013e3283554219","article-title":"Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse model","volume":"24","author":"Heindryckx","year":"2012","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118859_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jhep.2012.02.021","article-title":"Effect of prolyl hydroxylase domain-2 haplodeficiency on the hepatocarcinogenesis in mice","volume":"57","author":"Heindryckx","year":"2012","journal-title":"J. Hepatol."},{"issue":"16","key":"10.1016\/j.biopha.2025.118859_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22169023","article-title":"Doxorubicin paradoxically ameliorates tumor-induced inflammation in young mice","volume":"22","author":"Abdelgawad","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118859_bib39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.livres.2021.04.002","article-title":"A clinically relevant combination treatment with doxorubicin and cyclophosphamide does not induce hepatotoxicity in C57BL\/6J mice","volume":"5","author":"Pondugula","year":"2021","journal-title":"Liver Res."},{"issue":"217","key":"10.1016\/j.biopha.2025.118859_bib40","doi-asserted-by":"crossref","DOI":"10.3791\/66395","article-title":"Picrosirius red staining for semiquantitative histopathologic evaluation of collagen deposition in murine models of chronic lung allograft rejection","author":"Ohm","year":"2025","journal-title":"J. Vis. Exp."},{"issue":"125","key":"10.1016\/j.biopha.2025.118859_bib41","doi-asserted-by":"crossref","DOI":"10.3791\/56025","article-title":"Quantitative immunohistochemistry of the cellular microenvironment in patient glioblastoma resections","author":"Yuan","year":"2017","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.biopha.2025.118859_bib42","article-title":"Effects of taste signaling protein abolishment on gut inflammation in an inflammatory bowel disease mouse model","volume":"141","author":"Du","year":"2018","journal-title":"J. Vis. Exp."},{"issue":"60","key":"10.1016\/j.biopha.2025.118859_bib43","doi-asserted-by":"crossref","DOI":"10.3791\/3678","article-title":"Investigating intestinal inflammation in DSS-induced model of IBD","author":"Kim","year":"2012","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.biopha.2025.118859_bib44","doi-asserted-by":"crossref","DOI":"10.1172\/JCI181305","article-title":"Melanocortin-4 receptor antagonist TCMCB07 alleviates chemotherapy-induced anorexia and weight loss in rats","volume":"135","author":"Zhu","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2025.118859_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178282","article-title":"Statin-mediated protection in chemotherapy-induced intestinal and cardiac toxicity: current perspectives","author":"Arendt","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"7165","key":"10.1016\/j.biopha.2025.118859_bib46","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nature06196","article-title":"Identification of stem cells in small intestine and colon by marker gene Lgr5","volume":"449","author":"Barker","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biopha.2025.118859_bib47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00210-022-02311-6","article-title":"The progression of doxorubicin-induced intestinal mucositis in rats","volume":"396","author":"Kullenberg","year":"2023","journal-title":"Naunyn Schmiede Arch. Pharm."},{"issue":"22","key":"10.1016\/j.biopha.2025.118859_bib48","doi-asserted-by":"crossref","first-page":"7163","DOI":"10.1111\/febs.16145","article-title":"Targeting ER stress in the hepatic tumor microenvironment","volume":"289","author":"Pavlovic","year":"2022","journal-title":"FEBS J."},{"issue":"6","key":"10.1016\/j.biopha.2025.118859_bib49","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jhep.2024.01.032","article-title":"Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models","volume":"80","author":"Caon","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2025.118859_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109661","article-title":"Fibrin fragment E potentiates TGF-beta-induced myofibroblast activation and recruitment","volume":"72","author":"Fuchs","year":"2020","journal-title":"Cell Signal."},{"key":"10.1016\/j.biopha.2025.118859_bib51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.biopha.2025.118859_bib52","first-page":"1","article-title":"Crocin, the compound of the dried stigma of Crocus sativus L (saffron), restores doxorubicin-induced disturbances in kidney functioning, oxidative stress, inflammation, renal tissue morphology and TGF-beta signalling pathways","author":"Altinoz","year":"2024","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.biopha.2025.118859_bib53","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-024-07592-4","article-title":"Targeting BMP-1 enhances anti-tumoral effects of doxorubicin in metastatic mammary cancer: common and distinct features of TGF-beta inhibition","author":"Erin","year":"2025","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.biopha.2025.118859_bib54","doi-asserted-by":"crossref","first-page":"18944","DOI":"10.1038\/s41598-023-46216-7","article-title":"Doxorubicin-induced modulation of TGF-beta signaling cascade in mouse fibroblasts: insights into cardiotoxicity mechanisms","volume":"13","author":"Patricelli","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118859_bib55","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.55865","article-title":"Inhibiting IRE1alpha-endonuclease activity decreases tumor burden in a mouse model for hepatocellular carcinoma","volume":"9","author":"Pavlovic","year":"2020","journal-title":"eLife"},{"issue":"7","key":"10.1016\/j.biopha.2025.118859_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/biology10070640","article-title":"Exploring the role of endoplasmic reticulum stress in hepatocellular carcinoma through mining of the human protein atlas","volume":"10","author":"Pavlovic","year":"2021","journal-title":"Biology"},{"issue":"4","key":"10.1016\/j.biopha.2025.118859_bib57","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jhep.2018.06.009","article-title":"Mutational landscape of a chemically-induced mouse model of liver cancer","volume":"69","author":"Connor","year":"2018","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118859_bib58","doi-asserted-by":"crossref","first-page":"8013","DOI":"10.1038\/s41598-024-58587-6","article-title":"Proteomic analysis of DEN and CCl(4)-induced hepatocellular carcinoma mouse model","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2025.118859_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26041613","article-title":"Immunogenic cell death inducers in cancer immunotherapy to turn cold tumors into hot tumors","volume":"26","author":"Lucarini","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118859_bib60","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0162-3109(80)90021-1","article-title":"Doxorubicin and daunorubicin modulation of macrophages, T and B lymphocytes (anthracycline lymphocyte modulation)","volume":"2","author":"Orsini","year":"1980","journal-title":"Immunopharmacology"},{"issue":"6263","key":"10.1016\/j.biopha.2025.118859_bib61","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1126\/science.aad0779","article-title":"Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1","volume":"350","author":"Vacchelli","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2025.118859_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010079","article-title":"Transcriptional suppression of the NLRP3 inflammasome and cytokine release in primary macrophages by low-dose anthracyclines","volume":"9","author":"Kose-Vogel","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.118859_bib63","doi-asserted-by":"crossref","DOI":"10.1177\/09603271241231947","article-title":"Effects of doxorubicin on autophagy in fibroblasts","volume":"43","author":"Shuey","year":"2024","journal-title":"Hum. Exp. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118859_bib64","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/path.5678","article-title":"Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet?","volume":"254","author":"Lucantoni","year":"2021","journal-title":"J. Pathol."},{"issue":"16","key":"10.1016\/j.biopha.2025.118859_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169380","article-title":"MicroRNA-223 suppresses human hepatic stellate cell activation partly via regulating the actin cytoskeleton and alleviates fibrosis in organoid models of liver injury","volume":"23","author":"Ariyachet","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118859_bib66","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/cm.21230","article-title":"Stable incorporation of alpha-smooth muscle actin into stress fibers is dependent on specific tropomyosin isoforms","volume":"72","author":"Prunotto","year":"2015","journal-title":"Cytoskeleton"},{"key":"10.1016\/j.biopha.2025.118859_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119879","article-title":"Doxorubicin induces wide-spread transcriptional changes in the myocardium of hearts distinguishing between mice with preserved and impaired cardiac function","volume":"284","author":"Stamm","year":"2021","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118859_bib68","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/jcp.22167","article-title":"Post-transcriptional regulation of alpha-smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells","volume":"224","author":"Verjee","year":"2010","journal-title":"J. Cell Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118859_bib69","doi-asserted-by":"crossref","first-page":"729","DOI":"10.15252\/emmm.201505925","article-title":"Endoplasmic reticulum stress enhances fibrosis through IRE1alpha-mediated degradation of miR-150 and XBP-1 splicing","volume":"8","author":"Heindryckx","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biopha.2025.118859_bib70","doi-asserted-by":"crossref","DOI":"10.48101\/ujms.v129.10614","article-title":"Unboxing the network among long non-coding RNAs and TGF-beta signaling in cancer","volume":"129","author":"Rodrigues-Junior","year":"2024","journal-title":"Ups. J. Med. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2025.118859_bib71","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1002\/1878-0261.13215","article-title":"TGFbeta selects for pro-stemness over pro-invasive phenotypes during cancer cell epithelial-mesenchymal transition","volume":"16","author":"Tsubakihara","year":"2022","journal-title":"Mol. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118859_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051163","article-title":"Anthracyclins increase PUFAs: potential implications in ER stress and cell death","volume":"10","author":"Balgoma","year":"2021","journal-title":"Cells"},{"issue":"24","key":"10.1016\/j.biopha.2025.118859_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413181","article-title":"Correlation between oxidative stress and transforming growth factor-beta in cancers","volume":"22","author":"Chung","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"39","key":"10.1016\/j.biopha.2025.118859_bib74","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.2174\/0113816128326151240820105525","article-title":"Assessing TGF-beta prognostic model predictions for chemotherapy response and oncogenic role of FKBP1A in liver cancer","volume":"30","author":"Chen","year":"2024","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.biopha.2025.118859_bib75","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41467-024-55738-1","article-title":"Alleviation of liver fibrosis by inhibiting a non-canonical ATF4-regulated enhancer program in hepatic stellate cells","volume":"16","author":"Yang","year":"2025","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.biopha.2025.118859_bib76","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1158\/1078-0432.CCR-17-3125","article-title":"Activating transcription factor 4 modulates TGFbeta-induced aggressiveness in triple-negative breast cancer via SMAD2\/3\/4 and mTORC2 signaling","volume":"24","author":"Gonzalez-Gonzalez","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118859_bib77","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2147\/OTT.S60114","article-title":"Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis","volume":"7","author":"Vyas","year":"2014","journal-title":"Onco Targets Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118859_bib78","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.1038\/s41598-025-91133-6","article-title":"Mitigating doxorubicin-induced hepatotoxicity in male rats: the role of aerobic interval training and curcumin supplementation in reducing oxidative stress, endoplasmic reticulum stress and apoptosis","volume":"15","author":"Zobeydi","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118859_bib79","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/med.21921","article-title":"ER stress and inflammation crosstalk in obesity","volume":"43","author":"Ajoolabady","year":"2023","journal-title":"Med. Res. Rev."},{"issue":"8","key":"10.1016\/j.biopha.2025.118859_bib80","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.31557\/APJCP.2019.20.8.2551","article-title":"The carcinogenic agent diethylnitrosamine induces early oxidative stress, inflammation and proliferation in rat liver, stomach and colon: protective effect of ginger extract","volume":"20","author":"Mansour","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"4","key":"10.1016\/j.biopha.2025.118859_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0301379","article-title":"Doxorubicin causes cachexia, sarcopenia, and frailty characteristics in mice","volume":"19","author":"Cella","year":"2024","journal-title":"PLOS One"},{"issue":"3","key":"10.1016\/j.biopha.2025.118859_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26031177","article-title":"Distinct impact of doxorubicin on skeletal muscle and fat metabolism in mice: without dexrazoxane effect","volume":"26","author":"Van Asbroeck","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118859_bib83","first-page":"2","article-title":"Systemic and cardiac susceptibility of immune compromised mice to doxorubicin","volume":"5","author":"Favreau-Lessard","year":"2019","journal-title":"Cardiooncology"},{"issue":"15","key":"10.1016\/j.biopha.2025.118859_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e35123","article-title":"Determination of doxorubicin in plasma and tissues of mice by UPLC-MS\/MS and its application to pharmacokinetic study","volume":"10","author":"Jin","year":"2024","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.biopha.2025.118859_bib85","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.ajpath.2010.10.029","article-title":"Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model","volume":"178","author":"Bao","year":"2011","journal-title":"Am. J. Pathol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225010534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225010534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:53:04Z","timestamp":1777013584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225010534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":85,"alternative-id":["S0753332225010534"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118859","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparative study of idarubicin and doxorubicin in a chemically-induced in vivo mouse model for hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118859"}}